BerGenBio ASA Stock (OSE:BGBIO)

NORWAY |OL |NOK

Price
kr 20.36
Change
1.50%
Today's Range
kr 19.97 - kr 20.62
52-Week Range
kr 10.45 - kr 25.20
Market Cap
kr 1.08B
Volume
126.66K

About Bergenbio Asa (OSE:BGBIO)

(OSE:BGBIO) BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. Its lead candidate is Bemcentinib, a bioavailable small molecule AXL inhibitor, which is in Phase II clinical development in two major cancer indications. The Phase II clinical trial program focuses on lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as melanoma and triple negative breast cancer. In addition, it is developing tilvestamab, a function blocking antibody that is in Phase I clinical trial; and BGB601, a Phase I clinical trial antibody drug conjugate against human AXL that is linked to a cytotoxin. BerGenBio ASA has a collaboration agreement with Merck & Co. for clinical trials. The company was founded in 2007 and is headquartered in Bergen, Norway.
Show more

BGBIO Stock Price

Statistics Highlights (OSE:BGBIO)

Shares Outstanding 88.66M Beta 1.69
Public Float 45.15M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 35.66% Ex-Dividend Date
Held by Institutions 20.35% IPO Date -

BGBIO Financial Summary

|
Dec 21 Dec 20 Dec 19
Revenue kr774.00K kr601.00K kr8.90M
EBITDA kr-308.00M kr-256.27M kr-198.38M
Net Income kr-309.36M kr-257.03M kr-199.28M
Total Assets kr450.24M kr738.20M kr270.38M
Total Cash kr435.89M kr720.62M kr252.72M
Total Debt kr1.62M kr2.02M kr585.00K
Mar 22 Dec 21 Sep 21
Revenue kr0.00 kr774.00K kr0.00
EBITDA kr-77.85M kr-73.83M kr-68.06M
Net Income kr-81.07M kr-68.77M kr-70.50M
Total Assets kr380.60M kr450.24M kr514.99M
Total Cash kr367.83M kr435.89M kr509.41M
Total Debt kr kr1.62M kr1.02M

(OSE:BGBIO) Stock Price FAQs

What is today's stock price of Bergenbio Asa (OSE:BGBIO)?

  • The current stock price of Bergenbio Asa (OSE:BGBIO) is kr20.36.
  • Today BGBIO stock price opened at kr20.00 after previous close of kr20.06.
  • During the day, Bergenbio Asa stock quote has varied from a low of kr19.97 to a high of kr20.62.

What is Bergenbio Asa's 52-week change?

  • BGBIO 52-week high stock quote is kr25.20, which is 23.80% above the current share price.
  • The Bergenbio Asa (OSE:BGBIO) 52-week low stock price is kr10.45, which is 48.70% below the current share price.
  • Bergenbio Asa share price volatility (52-week beta) is 1.69.

Bergenbio Asa (OSE:BGBIO) FAQ

How Much is Bergenbio asa Worth?

Bergenbio asa's worth today based on market capitalisation is kr1.08B

How much dividend does Bergenbio asa Pay?

The current annualized dividend payout for BGBIO stock is kr0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Bergenbio asa's "Dividend" Section

When is the next earnings date for Bergenbio asa (OSE:BGBIO)?

Bergenbio asa is expected to report earnings on November 15 ,2022.
View More Details on Bergenbio asa's 'Earnings' Section

What is Bergenbio asa’s Price to Earning (PE) ratio?

BGBIO stock also has a Price to Sales (P/S) ratio of 1391.76.

What is the Bergenbio asa's ticker?

Bergenbio asa trades on the Oslo stock market in Norway under the ticker symbol "BGBIO". Bergenbio asa’s stock symbol can also be displayed as "OSE:BGBIO".

Who are the owners of Bergenbio asa?

Bergenbio asa (OSE:BGBIO) is owned by 20.35% institutional shareholders and by 35.66% insiders. The rest is owned by the public.
Explore More Details on Bergenbio asa's “Ownership” Section

Who are the key executives of Bergenbio asa (BGBIO)?

Bergenbio asa's key executive team includes the following managers:

  • Mr. Martin Olin, Chief Exec. Officer (1969)
  • Mr. Rune Skeie, Chief Financial Officer (1973)
  • Dr. James Barnes Ph.D., Chief Operating Officer (NA)
  • Dr. Nigel McCracken M.Sc., Ph.D., Chief Scientific Officer (NA)
  • Ms. Debbie Molyneux, Chief People Officer (NA)
  • Ms. Gayle M. Mills M.B.A, Chief Bus. Officer (1955)
  • Ms. Cristina Oliva M.D., Chief Medical Officer (NA)
  • Dr. Alison Messom, Director of Clinical Operations (1971)
  • Dr. Akil Jackson, Medical Director (NA)

What is Bergenbio asa’s Sector & Industry Classification?

Bergenbio asa (OSE:BGBIO) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Bergenbio asa?

Currently the number of employees working for Bergenbio asa is 43.

Where are Bergenbio asa's Headquarters?

Bergenbio asa (OSE:BGBIO) is headquartered in Norway.

What are Bergenbio asa's Address and Phone Number?

Bergenbio asa’s mailing address is Jonas Lies vei 91, Bergen, Norway, 5009.
The company’s phone number is 47 55 96 11 59.

What is the official website for Bergenbio asa?

Bergenbio asa’s official website is http://www.bergenbio.com